Clinical Trial Update: Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating inpatient stem cell transplantation for neurological sequelae after encephalitis or meningitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Encephalitis
• Meningitis

Drugs mentioned

• Stem cell transplantation

Snippet

Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology | Conditions: Encephalitis, Meningitis | Phase 1, Phase 2 | Status: COMPLETED